Joshi SS - Search Results

1

ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.

Joshi AD, Hegde GV, Dickinson JD, Mittal AK, Lynch JC, Eudy JD, Armitage JO, Bierman PJ, Bociek RG, Devetten MP, Vose JM, Joshi SS. Joshi AD, et al. Among authors: joshi ss. Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5295-304. doi: 10.1158/1078-0432.CCR-07-0283. Clin Cancer Res. 2007. PMID: 17875758

2

Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique.

Sharp JG, Joshi SS, Armitage JO, Bierman P, Coccia PF, Harrington DS, Kessinger A, Crouse DA, Mann SL, Weisenburger DD. Sharp JG, et al. Among authors: joshi ss. Blood. 1992 Feb 15;79(4):1074-80. Blood. 1992. PMID: 1737092 Free article.

3

Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10).

Vaughan WP, Civin CI, Weisenburger DD, Karp JE, Graham ML, Sanger WG, Grierson HL, Joshi SS, Burke PJ. Vaughan WP, et al. Among authors: joshi ss. Leukemia. 1988 Oct;2(10):661-6. Leukemia. 1988. PMID: 2459568

4

Detection of malignant cells in histologically normal bone marrow using culture techniques.

Joshi SS, Kessinger A, Mann SL, Stevenson M, Weisenburger DD, Vaughan WP, Armitage JO, Sharp JG. Joshi SS, et al. Bone Marrow Transplant. 1987 Feb;1(3):303-10. Bone Marrow Transplant. 1987. PMID: 2844335

5

Clinical outcome of peripheral blood stem cell support.

Kessinger A, Armitage J, Bierman P, Bishop M, Joshi S, Reed E, Sharp G, Talmadge J, Vose J. Kessinger A, et al. Med Oncol. 1994;11(2):43-6. doi: 10.1007/BF02988829. Med Oncol. 1994. PMID: 7850263 Review.

6

Increased hematopoietic progenitor cell maintenance in long-term bone marrow cultures containing minimal numbers of contaminating breast cancer cells.

Mann SL, Joshi SS, Crouse DA, Armitage JO, Kessinger A, Weisenburger DD, Vaughan WP, Sharp JG. Mann SL, et al. Among authors: joshi ss. Breast Cancer Res Treat. 1997 Jun;44(2):115-21. doi: 10.1023/a:1005732531318. Breast Cancer Res Treat. 1997. PMID: 9232270

7

Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies.

Pavletic ZS, Joshi SS, Pirruccello SJ, Tarantolo SR, Kollath J, Reed EC, Bierman PJ, Vose JM, Warkentin PI, Gross TG, Nasrati K, Armitage JO, Kessinger A, Bishop MR. Pavletic ZS, et al. Among authors: joshi ss. Bone Marrow Transplant. 1998 Jan;21(1):33-41. doi: 10.1038/sj.bmt.1701037. Bone Marrow Transplant. 1998. PMID: 9486492 Free PMC article.

8

Antitumor therapeutic potential of activated human umbilical cord blood cells against leukemia and breast cancer.

Joshi SS, Tarantolo SR, Kuszynski CA, Kessinger A. Joshi SS, et al. Clin Cancer Res. 2000 Nov;6(11):4351-8. Clin Cancer Res. 2000. PMID: 11106253

9

Blood stem cell transplantation: factors influencing cellular immunological reconstitution.

Sharp JG, Kessinger A, Lynch JC, Pavletic ZS, Joshi SS. Sharp JG, et al. Among authors: joshi ss. J Hematother Stem Cell Res. 2000 Dec;9(6):971-81. doi: 10.1089/152581600750062435. J Hematother Stem Cell Res. 2000. PMID: 11177612

10

Increased cytotoxicity against B-chronic lymphocytic leukemia by cellular manipulations: potentials for therapeutic use.

Vu UE, Pavletic ZS, Wang X, Joshi SS. Vu UE, et al. Among authors: joshi ss. Leuk Lymphoma. 2000 Nov;39(5-6):573-82. doi: 10.3109/10428190009113387. Leuk Lymphoma. 2000. PMID: 11342340

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters